| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |